| Jaw Muscle Pain Post Wisdom Molar Surgery (NCT07094542) | Rutgers, The State University of New Jersey | 2026-09-01 |
| Study of Oral HRS-5346 in Adult Patients With Elevated Lipoprotein(a) and High Risk of Cardiovascular Events (NCT07767513) | Shandong Suncadia Medicine Co., Ltd. | 2026-09-01 |
| Efficacy and Safety of Canadá Association in the Treatment of Chronic Pain (NCT05125978) | EMS | 2026-09-01 |
| Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders (NCT06333652) | Mayo Clinic | 2026-09-01 |
| A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer (NCT07414992) | Memorial Sloan Kettering Cancer Center | 2026-09-01 |
| HiCM-188 Cell Therapy in Adults With Advanced Heart Failure Undergoing Heart Bypass Surgery (NCT07646210) | HELP Therapeutics Co., Ltd. | 2026-09-01 |
| A Cognitive Mobile Intervention for Motivation in Psychotic Disorders (NCT07674914) | University of Alabama at Birmingham | 2026-09-01 |
| A Phase-II Clinical Trial of Radiotherapy to the Coeliac Plexus to Help Pain in Advanced Pancreatic Cancer (NCT07689955) | Royal Marsden NHS Foundation Trust | 2026-09-01 |
| SGLT2i Effect on PTDM Development and Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients: A Randomized, Doubleblind, Placebo Controlled, National Multicenter Trial (NCT07682350) | Odense University Hospital | 2026-09-01 |
| Nebulized Ketamine Plus Standard Care vs. Standard Care Alone in Moderate to Severe Asthma Exacerbations (NCT07112456) | Oman Medical Speciality Board | 2026-09-01 |
| A Study Evaluating the Safety of Inavolisib and Fulvestrant With or Without Palbociclib in Participants With Advanced Breast Cancer (ABC) and Type 2 Diabetes (NCT07748208) | Hoffmann-La Roche | 2026-09-01 |
| Ketamine Infusion for Symptomatic Improvement in Severe Borderline Personality Disorder (NCT07099534) | University Hospital, Toulouse | 2026-09-01 |
| L19IL2/L19TNF in Patients With Cutaneous Squamous Cell Carcinoma (NCT07228442) | Philogen S.p.A. | 2026-09-01 |
| SKB565 for Injection in Advanced Solid Tumors (NCT07545265) | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2026-09-01 |
| Efti in Patients With Hormone Receptor Positive/HER2-neg Breast Cancer (NCT07102940) | George Washington University | 2026-09-01 |
| Neoadjuvant Presurgical Becotatug Vedotin (MRG003) Plus Pucotenlimab (HX008) in Oral Cavity Squamous Cell Carcinoma (NCT07766889) | Sun Yat-sen University | 2026-09-01 |
| Vilamakitug in Spondyloarthritis Placebo-controlled Investigation for Efficacy (NCT06526377) | XBiotech, Inc. | 2026-09-01 |
| Dapagliflozin for Anemia in Lower-Risk Myelodysplastic Syndromes (NCT07516847) | Seug yun Yoon, MD | 2026-09-01 |
| Study to Evaluate the Safety, Tolerability, and Activity of CM-101 in Patients With Systemic Sclerosis (NCT06210945) | ChemomAb Ltd. | 2026-09-01 |
| Phase 1/2 Window Of Opportunity Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum (NCT07509008) | M.D. Anderson Cancer Center | 2026-09-01 |
| Testing Two Different Drugs (Sacituzumab-govitecan and Trastuzumab-deruxtecan) Combinations Prescribed in an Alterning Pattern to Patients With Metastatic or Locally Advanced Triple-negative Breast Cancer (NCT07151586) | UNICANCER | 2026-09-01 |
| Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (NCT07194980) | Fred Hutchinson Cancer Center | 2026-09-01 |
| A Randomized, Double-Blind Controlled Comparison of NRX-101 vs. Placebo for Adults Being Treated With Robotic Transcranial Magnetic Stimulation for Treatment Resistant Depression: The SPARC-TMS Trial (NCT07227103) | NeuroRx, Inc. | 2026-09-01 |
| The Optimal One-Month Dosing of Lemborexant for Moderate Obstructive Sleep Apnea (OSA) Patients With Low Arousal Threshold (NCT07683442) | Chulalongkorn University | 2026-09-01 |
| Study of CTX-471 in Patients With Neural Cell Adhesion Molecule (NCAM) Positive Neuroendocrine Neoplasms (NCT07684170) | Compass Therapeutics | 2026-09-01 |
| A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia (NCT07313852) | Memorial Sloan Kettering Cancer Center | 2026-09-01 |
| Teclistamab in Combination With Pomalidomide Administered in Alternative Fashion in Participants With Relapsed or Refractory Multiple Myeloma. (NCT07757412) | Odense University Hospital | 2026-09-01 |
| Intralesional Chemotherapy (IC): Cisplatin + Epinephrine (NCT07392580) | University of Miami | 2026-09-01 |
| Efficacy of Intracavernosal Xeomin With Tadalafil for Mild-Moderate Erectile Dysfunction (NCT07537855) | Northwestern University | 2026-09-01 |
| Venetoclax in Association With 3+7 and Midostaurin in FLT3-mutated Acute Myeloid Leukemia (NCT07726576) | University Hospital, Bordeaux | 2026-09-01 |
| Linzhi Jianghuang Fufang Huoxue Anshen Capsule for Non-alcoholic Fatty Liver (NCT07637006) | Hong Kong Baptist University | 2026-09-01 |
| Study of YKST02 in Adults With Relapsed or Refractory Multiple Myeloma (NCT07695740) | Excyte Biopharma Ltd | 2026-09-01 |
| INCREmental DIalysis and Diet for a Better Life Experience (NCT07699627) | Centre Hospitalier le Mans | 2026-09-01 |
| Levetiracetam Extended-Release Plus Stupp Protocol for Hypoxic IDH-Wildtype Glioblastoma (NCT07758062) | Tianjin Medical University General Hospital | 2026-09-01 |
| HRX215, A First Generation MKK4 Inhibitor Drug, for the Treatment of Patients With Colorectal Liver Metastasis After Undergoing a Portal Vein Embolization (NCT07612007) | Mayo Clinic | 2026-09-01 |
| A Phase 2 Study of the Safety and Efficacy of AV078 in Participants With Tuberous Sclerosis Complex (TSC) Refractory Epilepsy (NCT07680322) | Aeovian Pharmaceuticals, Inc. | 2026-09-01 |
| Phase II Trial of Pembrolizumab/Chemotherapy With Live Biotherapeutic Product MO-03 in Patients With Early Stage Triple Negative Breast Cancer (NCT07552181) | Yuan Yuan | 2026-09-01 |
| Re-evaluating the Duration in Children of TB Treatment (NCT07656012) | University of Wisconsin, Madison | 2026-09-01 |
| An Open-label Safety, Tolerability and Exploratory Efficacy Clinical Trial of PST-611 in Geographic Atrophy (NCT07705568) | Eyevensys | 2026-09-01 |
| Glenzocimab in Anterior Stroke With Large Ischemic Core Eligible for Endovascular Therapy (NCT06437431) | Fondation Ophtalmologique Adolphe de Rothschild | 2026-09-01 |
| Sota-ES - Sotatercept in Patients With Congenital Heart Disease and Eisenmenger´s Syndrome (NCT07498803) | Philipps University Marburg | 2026-09-01 |
| Fixed Duration Treatment With Combined Pirtobrutinib and Short Course Immuno-chemotherapy in Fit Patients With Previously Untreated Symptomatic Chronic Lymphocytic Leukemia (CLL). (NCT07624799) | French Innovative Leukemia Organisation | 2026-09-01 |
| Phase 2 Study of WGI-0301 Plus Lenvatinib in Patients With Advanced HCC (NCT07540832) | Zhejiang Haichang Biotech Co., Ltd. | 2026-09-01 |
| MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma. (NCT07574047) | Swiss Cancer Institute | 2026-09-01 |
| CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial (NCT06949800) | University of California, San Francisco | 2026-09-01 |
| L19IL2/TNF in Patients With Basal Cell Carcinoma (NCT07227870) | Philogen S.p.A. | 2026-09-01 |
| Clinical Trial of 2-HOBA in Pulmonary Arterial Hypertension (NCT06176118) | Vanderbilt University Medical Center | 2026-09-01 |
| Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma (NCT07303283) | Kai Hu | 2026-09-01 |
| Omission of Adjuvant Radiotherapy in Young Low-Risk Ductal Carcinoma In Situ Following Breast-Conserving Surgery (NCT07762924) | Fudan University | 2026-09-01 |
| Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapy (NCT07762716) | BreakBio Corp | 2026-09-01 |
| Double-Blind Trial of Everolimus for Improving Social Abilities in PTEN Germline Mutations (NCT07218575) | Boston Children's Hospital | 2026-09-01 |
| EGFR Targeted Photoimmunotherapy With ASP-1929 for Locally Advanced Pancreatic Cancer (NCT07698613) | Brown University | 2026-09-01 |
| Terbinafine for CSA-AKI Prevention (NCT07738328) | Guangdong Provincial People's Hospital | 2026-09-01 |
| A Study of Mezagitamab in Adults With Late Antibody-Mediated Rejection (AMR) After a Kidney Transplant (NCT07613359) | Takeda | 2026-09-01 |
| Safety and Tolerability of Subretinal OPGx-RDH12-1001 for LCA-Associated Inherited Retinal Degeneration (LCA-IRD) (NCT07681778) | Opus Genetics, Inc | 2026-09-01 |
| DCE-MRI for Neoadjuvant Treatment Assessment in Patients With Borderline Resectable Pancreatic Cancer (NCT07705919) | Ohio State University Comprehensive Cancer Center | 2026-09-01 |
| Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions (NCT06876038) | University of Massachusetts, Boston | 2026-09-01 |
| A Study on the Efficacy and Safety of Anrikefon for Postoperative Pain Relief Following Laparoscopic Cholecystectomy (NCT07741188) | Affiliated Hospital of Guangdong Medical University | 2026-09-01 |
| A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED) (NCT07418034) | University of Maryland, Baltimore | 2026-09-01 |
| Efficacy of Bimekizumab in Adults With Pyoderma Gangrenosum (NCT07767864) | Oregon Health and Science University | 2026-09-01 |
| A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients (NCT07398404) | Medical University of South Carolina | 2026-09-01 |
| Cancer Lipidome Adaptation and Resculping Through Omega-3 PUFAs in Breast Tumors (NCT07643428) | Medical College of Wisconsin | 2026-09-01 |
| A Study to Evaluate the Efficacy and Safety of IN-207907 Injection in Elderly Patients With Sarcopenia (NCT07668180) | HK inno.N Corporation | 2026-09-01 |
| Glofitamab in B-NHL Using Mid-Therapy Intratumoral Transcriptomics (NCT07748364) | Joshua Brody | 2026-09-01 |
| Personalized Neoantigen Vaccine Plus IL-12 (INO-9012) Versus Active Surveillance in Subjects With High-Risk HCC (NCT07722741) | Geneos Therapeutics | 2026-09-01 |
| AIPH-TB: AI-Optimised Pyrazinamide-Hydroxychloroquine vs Standard RIPE for Drug-Sensitive Pulmonary Tuberculosis - A Phase II RCT (NCT07467252) | Ministry of Health, Saudi Arabia | 2026-09-01 |
| Daridorexant for People With Insomnia and Alcohol Use Disorder Study (NCT07701928) | Sterling McPherson | 2026-09-01 |
| ctDNA-Guided CURB for OPD mNSCLC on TKI (CURB-TKI) (NCT06813664) | University Health Network, Toronto | 2026-09-01 |
| A Study of Polatuzumab Vedotin and Glofitamab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Within 12 Months After R-CHOP (NCT07702851) | Yonsei University | 2026-09-01 |
| Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Symptoms in Schizophrenia (NCT07759895) | Amit Lotan | 2026-09-01 |
| PROSECCO: A Phase 2, Single Arm, Neoadjuvant Study Evaluating Combination Cemiplimab, Fianlimab, And Ipilimumab In Patients With Surgically Resectable Melanoma (NCT07511036) | M.D. Anderson Cancer Center | 2026-09-01 |
| Effects of Nimodipine on Alcohol Drinking (NCT07681869) | Yale University | 2026-09-01 |
| Lorlatinib Plus Sacituzumab Tirumotecan With Peripheral ctDNA Guidance as First-Line Therapy for ALK Fusion-Positive NSCLC (NCT07750704) | Guangdong Association of Clinical Trials | 2026-09-01 |
| Propranolol for Early Secondary Prevention of Post-Traumatic Stress Disorder in Women Victims of Sexual Violence (NCT07452978) | University Hospital, Tours | 2026-09-01 |
| Sonrotoclax, Zanubrutinib and Rituximab in Previously Untreated Patients With Follicular Lymphoma (NCT07550855) | Sun Yat-sen University | 2026-09-01 |
| Single FrAction Interstitial BreaSt BracHytherApy (NCT07654257) | Virginia Commonwealth University | 2026-09-01 |
| Phase I/II Clinical Trials of SHR-8203 Injection in Participants With Advanced Solid Tumors (NCT07769242) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2026-09-01 |
| Safety and Efficacy of OTL78 (Zopocianine) (NCT07725523) | Clinton Bahler | 2026-09-01 |
| Universal Immunization to Fortify Immunotherapy Efficacy and Response (NCT07597070) | University of Florida | 2026-09-01 |
| MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer (NCT07644598) | Georgetown University | 2026-09-01 |
| A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of Juvenile Myoclonic Epilepsy (NCT07723963) | Jazz Pharmaceuticals | 2026-09-01 |
| Efficacy and Safety of Golidocitinib for Rapidly Progressive Interstitial Lung Disease (NCT07737249) | Peking Union Medical College Hospital | 2026-09-01 |
| DURATION-GC: FLOT Plus Durvalumab and TS-1 Plus Durvalumab for Resectable Gastric Cancer (NCT07757191) | Taipei Veterans General Hospital, Taiwan | 2026-09-01 |
| Neoadjuvant Angiogenesis-Targeting Bispecific Chemoimmunotherapy for TNBC (NCT07743632) | University of Kansas Medical Center | 2026-09-01 |
| Efficacy of EMONO as an add-on Therapy to Conventional Antidepressants for the Treatment of Depressive Symptoms in Nursing-home Residents With Neurocognitive Disorders: a Randomized Controlled Trial- (NCT06382389) | University Hospital, Tours | 2026-09-01 |
| Bendamustine Versus Fludarabine/Cyclophosphamide for Lymphodepletion in Chimeric Antigen Receptor T-cell Immunotherapy (CAR-T): a Randomized Trial. (NCT07593482) | Swiss Cancer Institute | 2026-09-01 |
| TriGlytza®-01 Versus Metformin in Overweight and Obese Adults With Type 2 Diabetes and Inadequate Glycaemic Control Despite Metformin Therapy (NCT07139405) | Myopharm Limited | 2026-09-01 |
| Lemborexant Use for Cognition Improvement in Postoperative Delirium in Elderly Patients: A Randomized Controlled Trial (NCT07695285) | Beijing Tiantan Hospital | 2026-09-01 |
| Herbal Supplement (Biocidin REMOVE) for Bacterial Overgrowth in Irritable Bowel Syndrome (NCT07768267) | Johns Hopkins University | 2026-09-01 |
| REctus Sheath Trial (NCT07068243) | Duke University | 2026-09-01 |
| Study Evaluating the Efficacy and Safety of the Addition of Ivosidenib to Oral Azacitidine (Onureg®) in Patients Over 55 With Acute Myeloid Leukemia (AML) and IDH1 Mutation, in Complete Remission After Intensive Chemotherapy. (NCT07463768) | French Innovative Leukemia Organisation | 2026-09-01 |
| Prospective Study on Radiation Induced Cardiotoxicity Assessed By PET-CT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT07761910) | Indiana University | 2026-09-01 |
| Autologous Stem Cell Therapy in Patients With Multiple System Atrophy (NCT07465198) | Biocells Medical | 2026-09-01 |
| Combination Therapy for Alcohol Use Disorder (NCT07249554) | Johns Hopkins University | 2026-09-01 |
| A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial) (NCT07766005) | Spyre Therapeutics, Inc. | 2026-09-01 |
| Screening for Brain Metastases (NCT07492121) | University of Zurich | 2026-09-01 |
| Cerebrolysin After Reperfusion in Extended-window EndoVascular Thrombectomy (NCT06339411) | Chang Gung Memorial Hospital | 2026-09-01 |
| Emetine for Viral Outbreaks (a.k.a. EVOLVE Antiviral Initiative) (NCT07016321) | Johns Hopkins University | 2026-09-01 |
| Glucagon-Like Peptide-1 Receptor Agonists to Attenuate Metabolic Risk in Individuals With Duchenne Muscular Dystrophy (NCT07642635) | Vanderbilt University Medical Center | 2026-09-01 |
| Acetylsalicylic Acid Versus Placebo as an add-on Treatment to Local Non-steroidal Anti-inflammatory Drug for the Management of Thrombotic Episodes in Superficial Venous Malformations in Children Aged 6 to 17 Years. (NCT07663825) | University Hospital, Tours | 2026-09-01 |